NR1I2 and breast carcinoma: Kaplan–Meier survival curves indicated that breast carcinoma patients presenting high PXR expression showed shorter DFS (Disease-free survival) times compared to those with low PXR expression at a non-significant level (Figure 2B, log-rank test, p = 0.2024).